Activation of STAT3 through combined SRC and EGFR signaling drives resistance to a mitotic kinesin inhibitor in glioblastoma.
Kenchappa RS, Dovas A, Argenziano MG, Meyer CT, Stopfer LE, Banu MA, Pereira B, Griffith J, Mohammad A, Talele S, Haddock A, Zarco N, Elmquist W, White F, Quaranta V, Sims P, Canoll P, Rosenfeld SS.
Kenchappa RS, et al.
Cell Rep. 2022 Jun 21;39(12):110991. doi: 10.1016/j.celrep.2022.110991.
Cell Rep. 2022.
PMID: 35732128
Free PMC article.